Australian healthcare company InhaleRx (ASX: IRX) has achieved significant advancements in its clinical trials involving cannabinoid (CBD)-derived drugs. The company has taken meaningful steps forward in...
Australian healthcare company InhaleRx (ASX: IRX) has achieved significant advancements in its clinical trials involving cannabinoid (CBD)-derived drugs. The company has taken meaningful steps forward in...